Medical device and MedTech insights, news, tips and more

Sparrow BioAcoustics Launches Software That Turns a Smartphone into a Stethoscope 

February 21, 2024

Sparrow Bioacoustics

Sparrow BioAcoustics recently unveiled its StethophoneTM software, which transforms smartphones into medical-grade stethoscopes. This innovative tool enables users to capture, analyze, and share crucial heart health data with medical professionals from any location.

In June 2023, Sparrow received FDA clearance for the downloadable application, making it the first FDA-cleared smartphone stethoscope software-as-a-medical-device (SaMD). The company later obtained additional FDA clearance for consumer use, empowering individuals to actively monitor their heart health.

StethophoneTM leverages a smartphone’s built-in microphone to capture the subtle sounds of the heart. These sounds are filtered through bioacoustics engineering to provide clear, medical-grade diagnostic signals. Sparrow believes that this technology could enhance the detection and diagnosis of both routine and complex cardiac conditions.

In addition to its diagnostic capabilities, StethophoneTM offers advanced visualizations that help practitioners interpret the device’s diagnostics. Some of these patterns and anomalies may not be as easily discernible using conventional cardiac diagnostics.

Mark Attila Opauzsky, CEO of Sparrow BioAcoustics, commented on the launch of StethophoneTM, saying, “We are at the forefront of a revolution in personalized heart health. StethophoneTM embodies our commitment to providing everyone with the power, agency, and access to fight heart disease right in their own hands. Launching on Valentine’s Day symbolizes our dedication to heart health and the love and care we invest in our products and the people they serve.”

Sparrow is already working on a next-generation version of StethophoneTM that will integrate AI functionalities.

See Full Press Release at the Source: Sparrow BioAcoustics Announces the Launch of Stethophone™ – Bringing the Future of Personalized Heart Care Closer to Home

Press Release by: Sparrow BioAcoustics

Legacy Med Search logo

Legacy MedSearch has more than 35 years of combined experience recruiting in the medical device industry. We pride ourselves on our professionalism and ability to communicate quickly and honestly with all parties in the hiring process. Our clients include both blue-chip companies and innovative startups within the MedTech space. Over the past 17 years, we have built one of the strongest networks of device professionals ranging from sales, marketing, research & , quality & regulatory, project management, field service, and clinical affairs.

We offer a variety of different solutions for hiring managers depending on the scope and scale of each individual search. We craft a personalized solution for each client and position with a focus on attracting the best possible talent in the shortest possible time frame.

Are you hiring?
Contact us to discuss partnering with Legacy MedSearch on your position.

More insights

March 7, 2024
FDA Clears Dexcom’s First Over-the-Counter Continuous Glucose Monitor
Learn More
March 1, 2024
FDA greenlights Boston Scientific’s Novel Drug-Coated Balloon for Coronary In-Stent Restenosis
Learn More
October 12, 2023
Brainomix and Nanoflex Robotics to Collaborate on an AI-Assisted Robotic System for Remote Stroke Intervention
Learn More

Begin your legacy now. We are your medtech and medical device talent advisory firm.